Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter eradication therapy in COPD
2006-005382-19Phase 4Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of omeprazole, amoxicillin and clarithromycin in chronic obstructive pulmonary disease (COPD) and Helicobacter pylori infection (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoints: Difference in mean sputum neutrophil count and Change in Chronic Respiratory Disease Questionnaire (CRQ) score. Started May 2007; status: completed.
02
Drugs
omeprazoleamoxicillinclarithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)Helicobacter pylori infection
Beyond the preview
Go deeper on 2006-005382-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005382-19.